Mother and child immunization in developing countries: Progress, problems, and future;Vaccinations de la mere et de l'enfant dans les pays en developpement: Succes, problemes et nouvelles orientations

Medecine Tropicale

Volumn 63, Issue 4-5, 2003, Pages 498-505

  Guerin, N ^a,b,c  

^a Comité Technique des Vaccinations ^*  (France)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c NONE   (France)

Author keywords

Expanded Program on Immunization; Hepatitis B; Immunization safety; Measles; Neonatal tetanus; Poliomyelitis; Yellow fever

Indexed keywords

DEVELOPING COUNTRY; HEALTH PROGRAM; HUMAN; IMMUNIZATION; MEDICAL PRACTICE; MEDICAL RESEARCH; REVIEW; WORLD HEALTH ORGANIZATION; ADULT; CHILD; FEMALE; INFANT; MEASLES; NEWBORN; POLIOMYELITIS; PREGNANCY; PREGNANCY COMPLICATION; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; TETANY;

VACCINE;

ADULT; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; MEASLES; POLIOMYELITIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TETANY; VACCINES; WORLD HEALTH ORGANIZATION;

EID: 1442314745     PISSN: 0025682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. SANTONI F - Le Programme élargi de vaccinations: 25 ans aujour-d'hui. Med Trop 2001; 61: 177-186.
2. Le point sur les vaccins et la vaccination dans le monde. OMS/UNICEF/Banque mondiale, Genève, 2002.
3. Global programme for vaccines and immunization. Expanded programme on immunization. Immunization policy WHO/EPI/GEN/95.03 REV 1. Genève, 1995.
4. Progrès vers l'éradication de la poliomyélite: situation en Afrique Centrale et Occidentale 1999-2000. REH 2001; 76: 158-162.
5. Progrès vers l'éradication mondiale de la poliomyélite. REH 2003; 78: 138-144.
6. BOMPART F - Eradication mondiale de la poliomyélite et stratégies vaccinales. Med Mal Infect 2003; 33: 119-124.
7. Vaccins et produits biologiques. Recommandations du groupe stratégique consultatif d'experts (SAGE). REH 2002; 77: 305-311.
8. Progrès vers l'élimination du tétanos néonatal 1989-98. REH 1999; 74: 73-80.
9. Évaluation du tétanos néonatal au Rajasthan, Inde. REH 2003; 78: 5-32.
10. FAUVEAU V, MAMDANI M, STEINGLASS R, KOBLINSKI M - Maternal tetanus: Magnitude, epidemiology and potential control measures. Int J Gynecol Obstet 1993; 40: 3-12.
11. Réduction de la mortalité rougeoleuse mondiale et élimination régionale de la maladie, 2000-2001 - Partie I. REH 2002; 77: 50-55. Partie II. REH 2002; 77: 58-61.
12. Vaccines & Biologicals Annual Report 2002. WHO/V&B/02.01. Genève, 2002.
13. Le BCG dans les programmes de vaccination. REH 2001; 76: 33-39.
14. World Health report 2002 - Statistical Annexes Death by cause, sex in WHO regions estimates for 2001. http://who.int/whr/2002/whr2002_ annex2.pdf.
15. CHANG MH, CHEN CJ, LAI MS et Coll - Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997; 336: 1855-1859.
16. Vaccination des adolescents. REH 2000; 75: 183-187.
17. SIMONSEN L, KANE A, LLOYD J et Coll - Unsafe injections in the developing world ans transmission of bloodborne pathogens: a review. Bull World Health Org 1999; 77: 789-800.
18. MILLER MA, PISANI E - The cost of unsafe injections. Bull World Health Org 1999; 77: 808-811.
19. KANE A, LLOYD J, SIMONSEN L, KANE M - Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates. Bull World Health Org 1999; 77: 801-807.